Table 2.
SNR | CRLB [%] NAA | CRLB [%] Cr | CRLB [%] Cho | CRLB [%] mI | |
---|---|---|---|---|---|
PAT group | 7 ± 1 | 5.6 ± 0.7 | 9.6 ± 1.5 | 10.4 ± 2.1 | 13.4 ± 3.5 |
HC group | 7 ± 1 | 5.2 ± 0.9 | 9.4 ± 1.2 | 10.8 ± 1.8 | 13.5 ± 3.2 |
PAT: subjects with COVID-19 IgG antibodies > 22 kU/l or with positive SARS-CoV-2 qPCR test at least two months before the MR examination; HC: subjects with COVID-19 IgG < 22 kU/lmean; SNR: signal-to-noise ratio; CRLB: Cramér-Rao Lower Bounds of the spectral fit, NAA: total N-acetylaspartate; Cr: total creatine; Cho: choline-containing compounds; mI: myo-inositol